Patents by Inventor Mark Y. Hansen

Mark Y. Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230093376
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Application
    Filed: November 23, 2022
    Publication date: March 23, 2023
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 11523919
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: December 13, 2022
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20210068996
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 11, 2021
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Publication number: 20210038413
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Application
    Filed: October 22, 2020
    Publication date: February 11, 2021
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Patent number: 10835397
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: November 17, 2020
    Assignee: W.L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Patent number: 10828185
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: November 10, 2020
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Publication number: 20200022828
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 23, 2020
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20190388252
    Abstract: An open stent (a stent having open space through its thickness at locations between the ends of the stent), incorporating flexible, preferably polymeric, connecting elements into the stent wherein these elements connect adjacent, spaced-apart stent elements. Preferably the spaced-apart adjacent stent elements are the result of forming the stent from a helically wound serpentine wire having space provided between adjacent windings. Other stent forms such as multiple, individual spaced-apart ring-shaped or interconnected stent elements may also be used. The connecting elements are preferably longitudinally oriented.
    Type: Application
    Filed: September 4, 2019
    Publication date: December 26, 2019
    Inventors: Joseph R. Armstrong, Edward H. Cully, Mark Y. Hansen, Brian L. Johnson, Bret J. Kilgrow, Larry J. Kovach, James D. Silverman
  • Patent number: 10507124
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 17, 2019
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Patent number: 10456281
    Abstract: An open stent (a stent having open space through its thickness at locations between the ends of the stent), incorporating flexible, preferably polymeric, connecting elements into the stent wherein these elements connect adjacent, spaced-apart stent elements. Preferably the spaced-apart adjacent stent elements are the result of forming the stent from a helically wound serpentine wire having space provided between adjacent windings. Other stent forms such as multiple, individual spaced-apart ring-shaped or interconnected stent elements may also be used. The connecting elements are preferably longitudinally oriented.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: October 29, 2019
    Assignee: W.L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Mark Y. Hansen, Brian L. Souter, Bret J. Kilgrow, Larry J. Kovach, James D. Silverman
  • Patent number: 10335298
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: July 2, 2019
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 10166128
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Grant
    Filed: November 13, 2012
    Date of Patent: January 1, 2019
    Assignee: W. L. Gore & Associates. Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Publication number: 20180153718
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Application
    Filed: November 22, 2017
    Publication date: June 7, 2018
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20180049898
    Abstract: An open stent (a stent having open space through its thickness at locations between the ends of the stent), incorporating flexible, preferably polymeric, connecting elements into the stent wherein these elements connect adjacent, spaced-apart stent elements. Preferably the spaced-apart adjacent stent elements are the result of forming the stent from a helically wound serpentine wire having space provided between adjacent windings. Other stent forms such as multiple, individual spaced-apart ring-shaped or interconnected stent elements may also be used. The connecting elements are preferably longitudinally oriented.
    Type: Application
    Filed: March 9, 2017
    Publication date: February 22, 2018
    Inventors: Joseph R. Armstrong, Edward H. Cully, Mark Y. Hansen, Brian L. Johnson, Bret J. Kilgrow, Larry J. Kovach, James D. Silverman
  • Patent number: 9839540
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: December 12, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 9795496
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: October 24, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 9737422
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: August 22, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20170216062
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Application
    Filed: April 19, 2017
    Publication date: August 3, 2017
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry
  • Patent number: 9622888
    Abstract: An open stent (a stent having open space through its thickness at locations between the ends of the stent), incorporating flexible, preferably polymeric, connecting elements into the stent wherein these elements connect adjacent, spaced-apart stent elements. Preferably the spaced-apart adjacent stent elements are the result of forming the stent from a helically wound serpentine wire having space provided between adjacent windings. Other stent forms such as multiple, individual spaced-apart ring-shaped or interconnected stent elements may also be used. The connecting elements are preferably longitudinally oriented.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: April 18, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Mark Y. Hansen, Brian L. Johnson, Bret J. Kilgrow, Larry J. Kovach, James D. Silverman
  • Publication number: 20170065400
    Abstract: The invention relates to medical devices and methods of using them. The devices are prostheses which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The prostheses are configured to have a lattice resistant to dilation and creep, which is defined by a plurality of openings. The prosthesis may also optionally have a stent disposed proximal to the lattice. In exemplary embodiments, the fluoropolymer is expanded polytetrafluoroethylene. The composite materials exhibit high elongation while substantially retaining the strength properties of the fluoropolymer membrane. In at least one embodiment, the lattice is made of a composite material that includes a least one fluoropolymer membrane including serpentine fibrils and an elastomer. A lattice including a generally tubular member formed of a composite material including a least one fluoropolymer membrane containing serpentine fibrils and an elastomer is also provided.
    Type: Application
    Filed: November 16, 2016
    Publication date: March 9, 2017
    Inventors: Joseph R. Armstrong, Edward H. Cully, Jeffrey B. Duncan, Mark Y. Hansen, William D. Montgomery, Wendy J. Terry